Tofogliflozin, a sodium-glucose cotransporter 2 inhibitor, improves pulmonary vascular remodeling due to left heart disease in mice
Author:
Funder
Japan Society for the Promotion of Science
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference39 articles.
1. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2. Pulmonary hypertension due to left heart disease;Vachiery;Eur Respir J,2019
3. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension;Galie;Kardiol Pol,2015
4. Definitions and diagnosis of pulmonary hypertension;Hoeper;Turk Kardiyol Dern Ars,2014
5. Pulmonary hypertension with left-sided heart disease;Guazzi;Nat Rev Cardiol,2010
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unlocking the Potential: Angiotensin Receptor Neprilysin and Sodium Glucose Co-Transporter 2 Inhibitors for Right Ventricle Dysfunction in Heart Failure;Medicina;2024-07-09
2. SGLT2 inhibitors as a potential therapeutic option for pulmonary hypertension: mechanisms and clinical perspectives;Critical Reviews in Clinical Laboratory Sciences;2024-06-07
3. Emerging therapies: Potential roles of SGLT2 inhibitors in the management of pulmonary hypertension;Respiratory Medicine;2024-06
4. Genetic variations in anti-diabetic drug targets and COPD risk: evidence from mendelian randomization;BMC Pulmonary Medicine;2024-05-15
5. Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension;Biomedicine & Pharmacotherapy;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3